Neo Ivy Capital Management Edwards Lifesciences Corp Transaction History

Neo Ivy Capital Management

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$82.37 - $107.29 $57,247 - $74,566	695 New	695 $57,000
Q2 2022 Aug 16, 2022	SELL	$86.5 - $128.27 $326,970 - $484,860	-3,780 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $170,171 - $214,199	1,669 Added 79.06%	3,780 $444,000
Q4 2021 Feb 15, 2022	SELL	$106.37 - $130.68 $605,777 - $744,222	-5,695 Reduced 72.96%	2,111 $273,000
Q3 2021 Nov 16, 2021	BUY	$102.91 - $122.75 $803,315 - $958,186	7,806 New	7,806 $539,000
Q1 2021 Oct 07, 2021	SELL	$78.68 - $90.67 $111,804 - $128,842	-1,421 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $54,627 - $69,517	-762 Reduced 34.91%	1,421 $130,000
Q3 2020 Nov 17, 2020	BUY	$67.19 - $87.44 $146,675 - $190,881	2,183 New	2,183 $174,000
Q2 2020 Aug 17, 2020	SELL	$57.54 - $76.95 $449,157 - $600,671	-7,806 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$57.54 - $76.95 $348,749 - $466,393	6,061 Added 347.34%	7,806 $539,000
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $66,298 - $102,465	-1,265 Reduced 42.03%	1,745 $329,000
Q4 2019 Feb 13, 2020	BUY	$71.7 - $82.09 $215,817 - $247,090	3,010 New	3,010 $702,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.